<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38166694</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>18</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>02</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Analysis of influencing factors on long COVID in COVID-19 patients infected with omicron variant three months after discharge: a cross-sectional study.</ArticleTitle><Pagination><StartPage>36</StartPage><MedlinePgn>36</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">36</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-023-08947-w</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The purpose of this study is to analyze the influencing factors associated with Long-COVID in patients infected with Omicron variant of COVID-19 in Changchun City, Jilin Province, China three months after discharge in March 2022.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this study, we conducted a telephone follow-up based on the real-world data collected from the Affiliated Hospital to Changchun University of Chinese Medicine, Changchun Tongyuan Shelter Hospital and Changchun Infectious Disease Hospital during the COVID-19 epidemic in Changchun in March 2022. We used the Global COVID-19 Clinical Platform Case Report Form for Post COVID condition as a follow-up questionnaire to collect the general information, past medical history, clinical symptoms, COVID-19 vaccine inoculation doses, and other relevant information to analyze the symptom characteristics of COVID-19 patients three months after discharge from the hospital and related factors affecting Long COVID.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 1,806 patients with COVID-19 were included in this study, 977 males and 829 females, with a mean age of 38.5 [30.0, 49.4] years, and the number of female patients suffering from Long COVID (50.87%) was greater than male patients (p&#x2009;=&#x2009;0.023). The binary logistic regression analysis of factors influencing Long COVID showed that smoking history (OR (95%CI)&#x2009;=&#x2009;0.551(0.425-0.714), p&#x2009;&lt;&#x2009;0.001, taking never smoking as a reference), allergy history (OR (95%CI)&#x2009;=&#x2009;1.618 (1.086-2.413), p-value 0.018, taking no allergy as a reference), first symptoms (OR (95%CI)&#x2009;=&#x2009;0.636 (0.501-0.807), p&#x2009;&lt;&#x2009;0.001, with no first symptoms as reference) and COVID-19 vaccine inoculation doses (OR (95%CI)&#x2009;=&#x2009;1.517 (1.190-1.933), p-value 0.001, with &#x2264;&#x2009;2 doses of COVID-19 vaccine inoculation doses as reference) constituted its influencing factors. The first symptoms of patients on admission mainly included fever (512 cases, 71.81%), cough (279 cases, 39.13%) and dry or itchy throat (211 cases, 29.59%). The most common symptoms of Long COVID were persistent fatigue (68 cases), amnesia (61 cases), insomnia (50 cases) and excessive sweating (50 cases).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The first symptoms on admission were predominantly fever, cough and dry or itchy throat. The most common symptoms of Long COVID were persistent fatigue, amnesia, insomnia and excessive sweating, and female patients were at a higher risk of Long COVID.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shang</LastName><ForeName>Hang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Changchun University of Chinese Medicine, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Tianying</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>EBM office, the Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>EBM office, the Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Pulmonary Disease Center, the Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Shaodan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Pulmonary Disease Center, the Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Pulmonary Disease Center, the Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Jixiang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>the Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Tan</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Pulmonary Disease Center, the Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>the Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China. jian-w222@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Jiajuan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>the Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China. gjj-2005@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Yingzi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>EBM office, the Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China. yingzi930@sina.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000647" MajorTopicYN="N">Amnesia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003371" MajorTopicYN="N">Cough</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005334" MajorTopicYN="N">Fever</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010351" MajorTopicYN="N">Patient Discharge</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007319" MajorTopicYN="Y">Sleep Initiation and Maintenance Disorders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cross-sectional study</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Omicron variant</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>4</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>3</Day><Hour>9</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38166694</ArticleId><ArticleId IdType="pmc">PMC10763267</ArticleId><ArticleId IdType="doi">10.1186/s12879-023-08947-w</ArticleId><ArticleId IdType="pii">10.1186/s12879-023-08947-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mahase E. Covid-19: WHO declares pandemic because of alarming levels of spread, severity, and inaction. BMJ. 2020;368:m1036. doi: 10.1136/bmj.m1036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1036</ArticleId><ArticleId IdType="pubmed">32165426</ArticleId></ArticleIdList></Reference><Reference><Citation>Lina B, Bauer J. SARS-CoV-2 genetic diversity: its impact on vaccine efficacy. Infect Dis Now. 2022;52(8S):2&#x2013;S3. doi: 10.1016/j.idnow.2022.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idnow.2022.09.008</ArticleId><ArticleId IdType="pmc">PMC9467922</ArticleId><ArticleId IdType="pubmed">36108974</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan Y, Li X, Zhang L, Wan S, Zhang L, Zhou F. SARS-CoV-2 Omicron variant: recent progress and future perspectives. Signal Transduct Target Ther. 2022;7(1):141. doi: 10.1038/s41392-022-00997-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00997-x</ArticleId><ArticleId IdType="pmc">PMC9047469</ArticleId><ArticleId IdType="pubmed">35484110</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A, Bernabei R, Landi F, Gemelli Against C-P-ACSG. Persistent symptoms in patients after Acute COVID-19. JAMA. 2020;324(6):603&#x2013;5. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>A Clinical Case Definition of Post COVID-. 19 Condition by a Delphi Consensus [Internet]. [cited 2021 Oct 6]. Available from: https://www.who.int/publications-detail-redirect/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Quan L, Chavarro JE, Slopen N, Kubzansky LD, Koenen KC, Kang JH, Weisskopf MG, Branch-Elliman W, Roberts AL. Associations of Depression, anxiety, worry, perceived stress, and loneliness prior to Infection with risk of Post-COVID-19 conditions. JAMA Psychiatry. 2022;79(11):1081&#x2013;91. doi: 10.1001/jamapsychiatry.2022.2640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2022.2640</ArticleId><ArticleId IdType="pmc">PMC9453634</ArticleId><ArticleId IdType="pubmed">36069885</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, Redfield S, Austin JP, Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedin K, van der Velden AW, Hansen MP, Moberg AB, Balan A, Bruno P, Coenen S, Johansen E, Kowalczyk A, Kurotschka PK et al. Initial symptoms and three months follow-up after acute COVID-19 in outpatients: an international prospective cohort study. Eur J Gen Pract 2023:2154074.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10249456</ArticleId><ArticleId IdType="pubmed">36655704</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasso M, Klicperov&#xe1;-Baker M, Koos S, Kosyakova Y, Petrillo A, Vlase I. The impact of the coronavirus crisis on European societies. What have we learnt and where do we go from here? &#x2013; introduction to the COVID volume. Eur Soc. 2021;23(sup1):2&#x2013;S32. doi: 10.1080/14616696.2020.1869283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14616696.2020.1869283</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao S, Lee GM, Razzaghi H, Lorman V, Mejias A, Pajor NM, Thacker D, Webb R, Dickinson K, Bailey LC, et al. Clinical features and Burden of Postacute Sequelae of SARS-CoV-2 Infection in children and adolescents. JAMA Pediatr. 2022;176(10):1000&#x2013;9. doi: 10.1001/jamapediatrics.2022.2800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2022.2800</ArticleId><ArticleId IdType="pmc">PMC9396470</ArticleId><ArticleId IdType="pubmed">35994282</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Ayuzo Del Valle NC, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, Villapol S. Long-COVID in children and adolescents: a systematic review and meta-analyses. Sci Rep. 2022;12(1):9950. doi: 10.1038/s41598-022-13495-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-13495-5</ArticleId><ArticleId IdType="pmc">PMC9226045</ArticleId><ArticleId IdType="pubmed">35739136</ArticleId></ArticleIdList></Reference><Reference><Citation>Asakawa T. Focusing on development of novel sampling approaches and alternative therapies for COVID-19: are they still useful in an era after the pandemic? Biosci Trends. 2022;16(6):386&#x2013;8. doi: 10.5582/bst.2022.01506.</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/bst.2022.01506</ArticleId><ArticleId IdType="pubmed">36504074</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM, Lifelines Corona Research I. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022;400(10350):452&#x2013;61. doi: 10.1016/S0140-6736(22)01214-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Yao Q, Gu X, Wang Q, Ren L, Wang Y, Hu P, Guo L, Liu M, Xu J, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021;398(10302):747&#x2013;58. doi: 10.1016/S0140-6736(21)01755-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Demko ZO, Yu T, Mullapudi SK, Varela Heslin MG, Dorsey CA, Payton CB, Tornheim JA, Blair PW, Mehta SH, Thomas DL et al. Post-acute sequelae of SARS-CoV-2 (PASC) impact quality of life at 6, 12 and 18 months post-infection. medRxiv 2022.</Citation></Reference><Reference><Citation>Cairns R, Hotopf M. A systematic review describing the prognosis of Chronic Fatigue Syndrome. Occup Med (Lond) 2005;55(1):20&#x2013;31. doi: 10.1093/occmed/kqi013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/occmed/kqi013</ArticleId><ArticleId IdType="pubmed">15699087</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18(9):e1003773. doi: 10.1371/journal.pmed.1003773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, Kang L, Guo L, Liu M, Zhou X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;32. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Li X, Gu X, Zhang H, Ren L, Guo L, Liu M, Wang Y, Cui D, Wang Y, et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respir Med. 2022;10(9):863&#x2013;76. doi: 10.1016/S2213-2600(22)00126-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00126-6</ArticleId><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue JK, Franko NM, McCulloch DJ, McDonald D, Magedson A, Wolf CR, Chu HY. Sequelae in adults at 6 months after COVID-19 Infection. JAMA Netw Open. 2021;4(2):e210830. doi: 10.1001/jamanetworkopen.2021.0830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, Lange F, Andersson JLR, Griffanti L, Duff E, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604(7907):697&#x2013;707. doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, Shchendrygina A, Escher F, Vasa-Nicotera M, Zeiher AM, et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in patients recently recovered from Coronavirus Disease 2019 (COVID-19) JAMA Cardiol. 2020;5(11):1265&#x2013;73. doi: 10.1001/jamacardio.2020.3557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Das-Munshi J, Chang CK, Bakolis I, Broadbent M, Dregan A, Hotopf M, Morgan C, Stewart R. All-cause and cause-specific mortality in people with mental disorders and intellectual disabilities, before and during the COVID-19 pandemic: cohort study. Lancet Reg Health Eur. 2021;11:100228. doi: 10.1016/j.lanepe.2021.100228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100228</ArticleId><ArticleId IdType="pmc">PMC8639185</ArticleId><ArticleId IdType="pubmed">34877563</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Tao M, Shang L, Liu Y, Pan G, Jin Y, Wang L, Hu S, Li J, Zhang M, et al. Assessment of Sequelae of COVID-19 nearly 1 year after diagnosis. Front Med (Lausanne) 2021;8:717194. doi: 10.3389/fmed.2021.717194.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.717194</ArticleId><ArticleId IdType="pmc">PMC8649686</ArticleId><ArticleId IdType="pubmed">34888318</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, Villapol S. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn KL, Katz GM, Bobos P, Sander B, McNaughton CD, Cheung AM, Herridge MS, Atzema CL, Born KB, Chan C et al. Understanding the post COVID-19 condition (long COVID) in adults and the expected burden for Ontario. Sci Briefs Ont COVID-19 Sci Advisory Tables 2022, 2022;3(65).</Citation></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of Post-coronavirus Disease 2019 (COVID-19) Condition or Long COVID: a Meta-analysis and systematic review. J Infect Dis. 2022;226(9):1593&#x2013;607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Bobkova P, Spiridonova E, Shikhaleva A, Gamirova A, Blyuss O, Nekliudov N, Bugaeva P, Andreeva M, DunnGalvin A, et al. Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19. Clin Exp Allergy. 2021;51(9):1107&#x2013;20. doi: 10.1111/cea.13997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cea.13997</ArticleId><ArticleId IdType="pmc">PMC8444748</ArticleId><ArticleId IdType="pubmed">34351016</ArticleId></ArticleIdList></Reference><Reference><Citation>Group P-CC. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med. 2022;10(8):761&#x2013;75. doi: 10.1016/S2213-2600(22)00127-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00127-8</ArticleId><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Tomasoni D, Falcinella C, Barbanotti D, Castoldi R, Mule G, Augello M, Mondatore D, Allegrini M, Cona A, et al. Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. 2022;28(4):611. doi: 10.1016/j.cmi.2021.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond) 2021;53(10):737&#x2013;54. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Darcis G, Bouquegneau A, Maes N, Thys M, Henket M, Labye F, Rousseau AF, Canivet P, Desir C, Calmes D, et al. Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 Infection: a monocentric prospective observational cohort study. Int J Infect Dis. 2021;109:209&#x2013;16. doi: 10.1016/j.ijid.2021.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.07.016</ArticleId><ArticleId IdType="pmc">PMC8278829</ArticleId><ArticleId IdType="pubmed">34273510</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, Brown JS, Denneny EK, Hare SS, Heightman M, Hillman TE, Jacob J, Jarvis HC, et al. Long-COVID&#x2019;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76(4):396&#x2013;8. doi: 10.1136/thoraxjnl-2020-215818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddad C, Bou Malhab S, Sacre H, Salameh P. Smoking and COVID-19: a scoping review. Tob Use Insights. 2021;14:1179173X21994612. doi: 10.1177/1179173X21994612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1179173X21994612</ArticleId><ArticleId IdType="pmc">PMC7890709</ArticleId><ArticleId IdType="pubmed">33642886</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO statement. : Tobacco use and COVID-19 [Internet]. [cited 2020 May 11]. Available from:https://www.who.int/news-room/detail/11-05-2020-who-statement-tobacco-use-and-covid-19].</Citation></Reference><Reference><Citation>Young-Wolff KC, Slama N, Alexeeff SE, Sakoda LC, Fogelberg R, Myers LC, Campbell CI, Adams AS, Prochaska JJ. Tobacco Smoking and Risk of SARS-CoV-2 Infection and Disease severity among adults in an Integrated Healthcare System in California. Nicotine Tob Res. 2023;25(2):211&#x2013;20. doi: 10.1093/ntr/ntac090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ntr/ntac090</ArticleId><ArticleId IdType="pmc">PMC9825324</ArticleId><ArticleId IdType="pubmed">35368066</ArticleId></ArticleIdList></Reference><Reference><Citation>Simons D, Shahab L, Brown J, Perski O. The association of Smoking status with SARS-CoV-2 Infection, hospitalization and mortality from COVID-19: a living rapid evidence review with bayesian meta-analyses (version 7) Addiction. 2021;116(6):1319&#x2013;68. doi: 10.1111/add.15276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/add.15276</ArticleId><ArticleId IdType="pmc">PMC7590402</ArticleId><ArticleId IdType="pubmed">33007104</ArticleId></ArticleIdList></Reference><Reference><Citation>Paleiron N, Mayet A, Marbac V, Perisse A, Barazzutti H, Brocq FX, Janvier F, Dautzenberg B, Bylicki O. Impact of Tobacco Smoking on the risk of COVID-19: a large Scale Retrospective Cohort Study. Nicotine Tob Res. 2021;23(8):1398&#x2013;404. doi: 10.1093/ntr/ntab004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ntr/ntab004</ArticleId><ArticleId IdType="pmc">PMC7953961</ArticleId><ArticleId IdType="pubmed">33420786</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, Curtis HJ, Mehrkar A, Evans D, Inglesby P, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430&#x2013;6. doi: 10.1038/s41586-020-2521-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2521-4</ArticleId><ArticleId IdType="pmc">PMC7611074</ArticleId><ArticleId IdType="pubmed">32640463</ArticleId></ArticleIdList></Reference><Reference><Citation>Boutou AK, Pitsiou G, Kontakiotis T, Kioumis I. Nicotine treatment and Smoking cessation in the era of COVID-19 pandemic: an interesting alliance. ERJ Open Res 2020, 6(3).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7418819</ArticleId><ArticleId IdType="pubmed">32802824</ArticleId></ArticleIdList></Reference><Reference><Citation>Lutchman D. Could the Smoking gun in the fight against COVID-19 be the (rh)ACE-2? Eur Respir J 2020, 56(1).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7236827</ArticleId><ArticleId IdType="pubmed">32398309</ArticleId></ArticleIdList></Reference><Reference><Citation>Tindle HA, Newhouse PA, Freiberg MS. Beyond Smoking Cessation: investigating Medicinal Nicotine to prevent and treat COVID-19. Nicotine Tob Res. 2020;22(9):1669&#x2013;70. doi: 10.1093/ntr/ntaa077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ntr/ntaa077</ArticleId><ArticleId IdType="pmc">PMC7239141</ArticleId><ArticleId IdType="pubmed">32383751</ArticleId></ArticleIdList></Reference><Reference><Citation>Garufi G, Carbognin L, Orlandi A, Tortora G, Bria E. Smoking habit and hospitalization for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related Pneumonia: the unsolved paradox behind the evidence. Eur J Intern Med. 2020;77:121&#x2013;2. doi: 10.1016/j.ejim.2020.04.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2020.04.042</ArticleId><ArticleId IdType="pmc">PMC7177104</ArticleId><ArticleId IdType="pubmed">32345527</ArticleId></ArticleIdList></Reference><Reference><Citation>Asakawa T, Cai Q, Shen J, Zhang Y, Li Y, Chen P, Luo W, Zhang J, Zhou J, Zeng H et al. Sequelae of long COVID, known and unknown: a review of updated information. Biosci Trends 2023.</Citation><ArticleIdList><ArticleId IdType="pubmed">36928222</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, Deng J, Liu Q, Du M, Liu M, Liu J. Long-term consequences of asymptomatic SARS-CoV-2 Infection: a systematic review and Meta-analysis. Int J Environ Res Public Health 2023, 20(2).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9863678</ArticleId><ArticleId IdType="pubmed">36674367</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bermingham C, Pouwels KB, Glickman M, Nafilyan V, Zaccardi F, Khunti K, Alwan NA, Walker AS. Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. BMJ. 2022;377:e069676. doi: 10.1136/bmj-2021-069676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069676</ArticleId><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Raw RK, Kelly CA, Rees J, Wroe C, Chadwick DR. Previous COVID-19 Infection, but not Long-COVID, is associated with increased adverse events following BNT162b2/Pfizer vaccination. J Infect. 2021;83(3):381&#x2013;412. doi: 10.1016/j.jinf.2021.05.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.05.035</ArticleId><ArticleId IdType="pmc">PMC8164507</ArticleId><ArticleId IdType="pubmed">34062184</ArticleId></ArticleIdList></Reference><Reference><Citation>Marco JJG, Pasquin MJA, Martin SM, Miranda APJ. Papel protector de las actuales vacunas para las variantes del virus SARS-CoV-2 Y La COVID persistente. FMC. 2022;29(1):16&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8788134</ArticleId><ArticleId IdType="pubmed">35095266</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra PK, Bruiners N, Ukey R, Datta P, Onyuka A, Handler D, Hussain S, Honnen W, Singh S, Guerrini V et al. Vaccination boosts protective responses and counters SARS-CoV-2-induced pathogenic memory B cells. medRxiv 2021.</Citation></Reference><Reference><Citation>Self-reported long COVID after infection with the Omicron variant in the UK. : 18 July 2022 [Internet]. [cited 2022 July 18]. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/selfreportedlongcovidafterinfectionwiththeomicronvariant/18july2022.</Citation></Reference><Reference><Citation>Kannan S, Shaik Syed Ali P, Sheeza A. Omicron (B.1.1.529) - variant of concern - molecular profile and epidemiology: a mini review. Eur Rev Med Pharmacol Sci. 2021;25(24):8019&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">34982466</ArticleId></ArticleIdList></Reference><Reference><Citation>Han P, Li L, Liu S, Wang Q, Zhang D, Xu Z, Han P, Li X, Peng Q, Su C, et al. Receptor binding and complex structures of human ACE2 to spike RBD from Omicron and delta SARS-CoV-2. Cell. 2022;185(4):630&#x2013;640e610. doi: 10.1016/j.cell.2022.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.001</ArticleId><ArticleId IdType="pmc">PMC8733278</ArticleId><ArticleId IdType="pubmed">35093192</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Z, Liu P, Wang N, Wang L, Fan K, Zhu Q, Wang K, Chen R, Feng R, Jia Z, et al. Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron. Cell. 2022;185(5):860&#x2013;871e813. doi: 10.1016/j.cell.2022.01.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.019</ArticleId><ArticleId IdType="pmc">PMC8786603</ArticleId><ArticleId IdType="pubmed">35120603</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Wang R, Gilby NB, Wei GW. Omicron variant (B.1.1.529): infectivity, vaccine breakthrough, and antibody resistance. J Chem Inf Model. 2022;62(2):412&#x2013;22. doi: 10.1021/acs.jcim.1c01451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jcim.1c01451</ArticleId><ArticleId IdType="pmc">PMC8751645</ArticleId><ArticleId IdType="pubmed">34989238</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399(10343):2263&#x2013;4. doi: 10.1016/S0140-6736(22)00941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren J, Pang W, Luo Y, Cheng D, Qiu K, Rao Y, Zheng Y, Dong Y, Peng J, Hu Y, et al. Impact of allergic Rhinitis and Asthma on COVID-19 Infection, hospitalization, and Mortality. J Allergy Clin Immunol Pract. 2022;10(1):124&#x2013;33. doi: 10.1016/j.jaip.2021.10.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2021.10.049</ArticleId><ArticleId IdType="pmc">PMC8556867</ArticleId><ArticleId IdType="pubmed">34728408</ArticleId></ArticleIdList></Reference><Reference><Citation>Holt H, Talaei M, Greenig M, Zenner D, Symons J, Relton C, Young KS, Davies MR, Thompson KN, Ashman J, et al. Risk factors for developing COVID-19: a population-based longitudinal study (COVIDENCE UK) Thorax. 2022;77(9):900&#x2013;12. doi: 10.1136/thoraxjnl-2021-217487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2021-217487</ArticleId><ArticleId IdType="pubmed">34848555</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakharia N, Subramanian AK, Shapiro AE. COVID-19 in the immunocompromised host, including people with human immunodeficiency virus. Infect Dis Clin North Am. 2022;36(2):397&#x2013;421. doi: 10.1016/j.idc.2022.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idc.2022.01.006</ArticleId><ArticleId IdType="pmc">PMC8806148</ArticleId><ArticleId IdType="pubmed">35636907</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>